You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
羅欣藥業(002793.SZ)第三季度淨利潤預增不超55.11%
格隆匯 10-14 21:25

格隆匯 10 月 14日丨羅欣藥業(002793.SZ)公佈,預計2020年前三季度歸屬於上市公司股東的淨利潤3.2億元-3.8億元;其中,第三季度歸屬於上市公司股東的淨利潤10492萬元-16492萬元,與上年同期重組後數據相比下降1.32%-增長55.11%。

公司2020年前三季度業績與上年同期相比有所下降的主要原因為受新型冠狀病毒肺炎疫情影響,各級醫療終端門診量、手術量減少,公司消化、呼吸、抗生素等領域的產品受到影響,銷售量有所下降。目前隨着疫情影響逐漸減弱,各級醫療終端門診量、手術量逐步恢復,公司相關產品的銷售量已逐步回升到接近正常水平。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account